Hangzhou Tigermed Consulting Co., Ltd
HNGZY
$3.96
-$0.14-3.38%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 98.77% | -15.36% | -30.52% | -382.15% | -33.98% |
| Total Depreciation and Amortization | -1.75% | 1.88% | -- | 6.43% | -10.68% |
| Total Amortization of Deferred Charges | -6.76% | 6.89% | -- | 20.12% | -30.72% |
| Total Other Non-Cash Items | 48.14% | -136.42% | 135.27% | -6.99% | 36.48% |
| Change in Net Operating Assets | -86.20% | 86.18% | -- | 75.47% | 8.76% |
| Cash from Operations | -17.55% | 536.97% | 35.48% | 8.87% | 36.47% |
| Capital Expenditure | 4.00% | 41.78% | 57.44% | 21.84% | -37.01% |
| Sale of Property, Plant, and Equipment | 107.23% | 1,857.05% | -85.76% | 317.48% | 72.92% |
| Cash Acquisitions | -359.57% | -100.00% | -- | -4,737.05% | 92.86% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 163.34% | 117.11% | -7,025.11% | 749.50% | -111.78% |
| Cash from Investing | 140.67% | 115.65% | -442.40% | 1,594.69% | -26.05% |
| Total Debt Issued | -97.35% | -60.22% | 48.89% | 36.24% | -1.71% |
| Total Debt Repaid | 28.05% | -33.67% | -284.82% | -143.39% | -38.00% |
| Issuance of Common Stock | 65.13% | -- | 193.90% | -52.37% | 19.45% |
| Repurchase of Common Stock | -- | -33.72% | -- | -807.51% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 87.22% | -622.28% | 11.75% | -76.05% | -6.17% |
| Other Financing Activities | -29.05% | 540.44% | -34.81% | 268.77% | 2.69% |
| Cash from Financing | -79.42% | -455.35% | -4,328.55% | -197.46% | -230.91% |
| Foreign Exchange rate Adjustments | 50.70% | 43.78% | 196.46% | 210.66% | -538.64% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 92.46% | 104.72% | -2,625.76% | 117.37% | -65.08% |